Edward M. MD Kaye - Dec 1, 2024 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Signature
/s/ Jonathan Allan, Attorney-in-Fact
Stock symbol
STOK
Transactions as of
Dec 1, 2024
Transactions value $
$0
Form type
4
Date filed
12/3/2024, 04:13 PM
Previous filing
Oct 3, 2024
Next filing
Dec 10, 2024

Transactions Table

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STOK Restricted Stock Unit (RSU) Options Exercise $0 -21.6K -83.34% $0.00 4.32K Dec 1, 2024 Common Stock 21.6K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
F2 21,591 restricted stock units will vest on December 1, 2024 and 4,317 will vest on December 1, 2025, subject to the reporting person's continued service to the Issuer on each such date.